The immunopathology of siliconosis: History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone

Immunologic Research

Volumn 18, Issue 3, 1998, Pages 125-173

  Shanklin, Douglas R ^a   Smalley, David L ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Baptist Regional Laboratories   (United States)

Author keywords

Autoimmune; Chemical toxicity; Conversion; Granulomas; Immune; Medical device failure; Persistent antigen; Silica; Silicone; Siliconosis; Silicosis; T cell mediated process

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SILICONE; SILOXANE;

ANTIGEN PRESENTATION; AUTOIMMUNITY; BREAST ENDOPROSTHESIS; CELLULAR IMMUNITY; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; DEVICE; GRANULOMA; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOPATHOLOGY; IMPLANT; LUNG BIOPSY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SILICOSIS; T LYMPHOCYTE;

EID: 0032463169     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02788777     Document Type: Review

References (552)

1. Shanklin DR, Smalley DL: Silicone immunopathology. Sci Med 1996;3:5:22-31.
2. Barondes RD, Judge WD, Towne CG, Baxter ML: The silicones in medicine: new organic derivatives and some of their unique properties. Milit Surg 1950;106: 379-387.
3. U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Silicone in medical devices, 1991, HHS Publication FDA 92-4249, 330 pp.
4. Borenstein D: Siliconosis: a spectrum of disease. Sem Arthritis Rheum 1994;24(Suppl 1):1-7.
5. Shanklin DR, Smalley DL: Quantitative aspects of cellular response to silicone. Int J Occup Med Tox 1995; 4:99-111.
6. Goin JM: High pressure injection of silicone gel into an axilla: a complicalion of closed compression capsulotomy of the breast. Plast Reconstr Surg 1978;62:891-895.
7. Hipps CJ, Raju DR, Straith RE: Influence of some operative and postoperative factors on capsular contracture around breast prostheses. Plast Reconstr Surg 1978; 61:384-389.
8. Rudolph R, Abraham J, Vecchione T, Guber S, Woodward T: Myofibroblasts and free silicon around breast implants. Plast Reconstr Surg 1978;62:185-196.
9. Smahel J: Foreign material in the capsules around breast prostheses and the cellular reaction to it. Br J Plast Surg 1979;32:35-42.
10. Gayou RM: A histological comparison of contracted and non-contracted capsules around silicone breast implants. Plast Reconstr Surg 1979;63:700-707.
11. Sturrock RD: Silicone gel breast implants; the report of the independent review group. London, UK, Department of Health, July 14, 1998, p 15.
12. Sterner JH, Eisenbud M: Epidemiology of beryllium intoxication. Arch Ind Occup Med 1951; 3: 123-151.
13. Eisenbud M, Lission J: Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update. J Occup Med 1983;25: 196-202.
14. Williams WJ, Williams WR: Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers. Thorax 1983;38:41-44.
15. Rossman MD, Kern JA, Elias JA, Cullen MR, Epstein PE, Preuss OP, Markham TN, Daniele RD: Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann Int Med 1988;108: 687-693.
16. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG: Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989;320:1103-1109.
17. Clarke SM: A novel enzyme-linked immunosorbent assay (ELISA) for the detection of beryllium antibodies. J Immunol Methods 1991;137: 65-72.
18. Williams WJ: United Kingdom beryllium registry: mortality and autopsy study. Environ Health Perspect 1996;104(Suppl 5): 949-951.
19. Sabin FR, Doan CA: The biological reactions in rabbits to the protein and phosphatide fractions from the chemical analysis of human tubercle bacilli. J Exp Med 1927;46:645-669.
20. Sabin FR, Doan CA, Forkner CE: Studies on tuberculosis. J Exp Med 1930;52(Suppl 3):1-152. (See especially, Chapter 4, pp 113-152: The relation of the tubercle and the monocyte-lymphocyte ratio to resistance and susceptibility).
21. Sabin FR: Cellular studies in tuberculosis. Am Rev Tuberc 1932; 25:153-171.
22. Sabin FR: Cellular reactions to fractions isolated from tubercle bacilli. Physiol Rev 1932;12: 141-165.
23. Rich AR, Lewis MR: The nature of allergy in tuberculosis as revealed by tissue culture studies. Bull Johns Hopkins Hosp 1932; 50:115-126.
24. Waksman BH, Matoltsy M: The effect of tuberculin on peritoneal exudate cells of sensitized guinea-pigs in surviving cell culture. J Immunol 1958;81:220-234.
25. Pearmain G, Lycette RR, Fitzgerald PH: Tuberculin-induced mitosis in peripheral blood leucocytes. Lancet 1963;1:637-638.
26. Marshall, WH, Roberts KB: Tuberculin-induced mitosis in peripheral blood leucocytes. Lancet 1963;1:773.
27. Elves MW, Roath S, Israels MCG: The response of lymphocytes to antigen challenge in vitro. Lancet 1963;1:806-807.
28. 14C incorporation by lymphocytes. J Immunol 1967;98: 1274-1285.
29. Zweiman B: Temporal relationships between tuberculin skin reactivity and in vitro mitotic response. Immunol 1967;13:315-318.
30. Toossi Z, Ellner JJ: The role of TGFβ in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol 1998;87:107-114.
31. Bloom BR, Modlin RL, Salgame P: Stigma variations: observations on suppressor T cells and leprosy. Ann Rev Immunol 1992;10: 453-488.
32. Boros DL: Granulomatous inflammations. Prog Allergy 1978;24: 183-267.
33. Boros DL, Warren KS: The bentonite granuloma: characterization of a model system for infections and foreign body granulomatous inflammation using soluble mycobacterial, histoplasma and schistosoma antigens. Immunology 1973;24:511-529.
34. Boros DL: Immunoregulation of granuloma formation in murine schistosomiasis Mansoni. Ann NY Acad Sci 1980;465:313-323.
35. Warren KS: The pathology, pathobiology and pathogenesis of schistosomiasis. Nature 1978;273: 609-612.
36. von Lichtenberg F, Sher A, McIntyre S: A lung model of schistosome immunity in mice. Am J Pathol 1977;87:105-123.
37. Goldring OL, Clegg JA, Smithers SR, Terry RJ: Acquisition of human blood group antigens by Schistosoma mansoni. Clin Exp Immunol 1976;26:181-187.
38. Sher A, Hall BF, Vadas MA: Acquisition of murine major histocompatibility complex gene products by schistosomula of Schistosoma mansoni. J Exp Med 1978;148: 46-57.
39. Moser G, Wassom DL, Sher A: Studies on the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. I. Evidence that the loss in susceptibility to immune damage undergone by developing schistosomula involves a change unrelated to the masking of parasite antigens by host molecules. J Exp Med 1980; 152:41-53.
40. Samuelson JC, Sher A, Caulfield JP: Newly transformed schistosomula spontaneously lose surface antigens and C3 acceptor sites during culture. J Immunol 1980; 124:2055-2057.
41. Sher A, Moser G: Schistosomiasis. Immunologic properties of developing schistosomula. Am J Pathol 1981;102:121-126.
42. Shanklin DR, Smalley DL: Differential capsulopathy by silicone implant type. Lab Invest 1996; 74:24A (Abstract #123).
43. Randall T: Penile, testicular, other silicone implants soon will undergo FDA review. J Am Med Assoc 1992;267:2578-2579.
44. Randall T: Less maligned, but cut from the same cloth, other silicone implants also have the adverse effects. J Am Med Assoc 1992; 268:12-13.
45. Randall T: Surgeons grapple with synovitis, fractures around silicone implants for hand and wrist. J Am Med Assoc 1992;268:13, 17-18.
46. Wassermann RJ, Greenwald DP: Debilitating silicone granuloma of the penis and scrotum. Ann Plast Surg 1995;35:505-510.
47. Kagan H: Sakurai injectable silicone formula. Arch Otolaryngol 1963:78:663-668.
48. Palazzolo RJ, McHard JA, Hobbs EJ, Fancher OE, Calandra JC: Investigation of toxicologic properties of a phenylmethylcyclosiloxane. Toxicol Appl Pharmacol 1972;21:15-28.
49. LeFevre R, Coulston F, Goldberg L: Action of a copolymer of mixed phenylmethylcyclosiloxanes on reproduction in rats and rabbits. Toxicol Appl Pharmacol 1972;21: 29-44.
50. Hobbs EJ, Fancher OE, Calandra JC. Effect of selected organopolysiloxanes on male rat and rabbit reproductive organs. Toxicol Appl Pharmacol 1972;21:45-54.
51. Hayden JF, Barlow SA: Structure-activity relationships of organosiloxanes and the female reproductive system. Toxicol Appl Pharmacol 1972:21:68-79.
52. LeVier RR, Jankowiak ME: Effects of oral 2,6-cis-diphenylhexamethylcyclotetrasiloxane on the reproductive system of the male rat. Toxicol Appl Pharmacol 1972; 21:81-88.
53. Nicander L: Changes produced in the male genital organs of rabbits and dogs by 2,6-cis-diphenylhexamethylcyclotetrasiloxane (KABI 1774). Acta Pharmacol Toxicol 1975;36:40-54.
54. LeVier RR, Boley WF: The antigonadotropic activity of an organosiloxane in the male rat: 2,6-cis-diphenylhexamethylcyclotetrasiloxane. Acta Pharmacol Toxicol 1975:36:55-67.
55. Levier RR, Bennett DR, Hunter MJ: Effects of oral 2,6-cis-diphenylhexamethylcyclotetrasiloxane on the reproductive system of the male Macaca mulatta. Acta Pharmacol Toxicol 1975;36:68-80.
56. LeVier RR, Jankowiak ME: The hormonal and antifertility activity of 2,6-cis-diphenylhexamethylcyclotetrasiloxane in the female rat. Acta Pharmacol Toxicol 1975; 36:81-92.
57. 14C-labelled KABI 1774. Acta Pharmacol Toxicol 1975:36:131-138.
58. Levine JJ, Ilowite NT: Seleroderma-like esophageal disease in children breast fed from mothers with breast implants. Clin Res 1993;41:320A.
59. Levine JJ, Ilowite NT: Scleroderma-like esophageal disease in children breast fed from mothers with breast implants. J Am Med Assoc 1994;271:213-216.
60. Levine JJ, Lin HC, Rowley M, Cook A, Teuber SS, Ilowite NT: Lack of autoantibody expression in children born to mothers with silicone breast implants. Pediatrics 1995:97:243-245.
61. + and neopterin excretion in children breast fed by mothers with silicone breast implants: evidence for macrophage activation. J Rheumatol 1996; 23: 1083-1087.
62. Levine JJ, Trachtman H, Gold DM, Pettei MJ: Esophageal dysmotility in children breast-fed by mothers with silicone breast implants. Diges Dis Sci 1996;41:1600-1603.
63. Shanklin DR, Smalley DL, Russano J: Second generation silicone disease. J Invest Med 1996;44:17A.
64. Smalley DL, Levine JJ, Shanklin DR, Hall MF, Stevens MV: Lymphocyte response to silica among offspring of silicone breast implant recipients. Immunobiology 1996/97;196:567-574.
65. Kala SV, Lykissa ED, Lebovitz RM: Detection and characterization of poly(dimethylsiloxane)s in biological tissues by GC/AED and GC/MS. Anal Chem 1997; 69:1267-1272.
66. Lykissa ED, Kala SV, Hurley JB, Lebovitz RM: Release of low molecular weight silicones and platinum from silicone breast implants. Anal Chem 1997;69: 4912-4916.
67. Kala SV, Lykissa ED, Neely MW, Lieberman MW: Low molecular weight silicones are widely distributed after a single subcutaneous injection in mice. Am J Pathol 1998;152:645-649.
68. 4) in rat urine. Dow Corning Corporation, Document 1997-10000-43454, Midland, MI, August 26, 1997.
69. Cutting WC: Toxicity of silicones. Stan Med Bull 1952;10:23-26.
70. Pearson CM: Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956;91:95-101.
71. Reed WA, Kittle CF: Observations on toxicity and use of antifoam. AMA Arch Surg 1959;78: 220-225.
72. Smith WT: Cerebral lesions due to emboli of silicone antifoam in dogs subjected to cardiopulmonary bypass. J Path Bact 1960;80: 9-18.
73. Fregert S, Rorsman H: Allergy to a carbon-functional organic silicon compound, dimethyldi-(4- hydroxyphenyl)-silane. Nature 1961;192:989-990.
74. Little K, Parkhouse J: Tissue reactions to polymers. Lancet 1962;2: 857-861.
75. Winer LH, Standberg TH, Lehman R, Ashley FL: Tissue reactions to injected silicone liquids: a report of three cases. Arch Dermatol 1964;90:588-593.
76. Ballantyne DL, Rees TD, Seidman I: Silicone fluid: response to massive subcutaneous injections of dimethylpolysiloxane fluid in animals. Plast Reconstr Surg 1965; 36:330-338.
77. Ben-Hur N, Neuman Z: Siliconoma: another cutaneous response to dimethylpolysiloxane. Experimental study in mice. Plast Reconstr Surg 1965:36:629-631.
78. Hanna C, Shibley S: Tissue reaction to intracorneal silicone rubber (Silastic RTV 382) and methyl-2-cyanoacrylate (Eastman 910 adhesive). Am J Ophthal 1965;60: 323-328.
79. Rees TD, Platt I, Ballantyne DL: An investigation of cutaneous response to dimethylpolysiloxane (silicone liquid) in animals and humans: a preliminary report. Plast Reconstr Surg 1965;35:131-139.
80. Andrews J: Cellular behavior to injected silicone fluid: a preliminary report. Plast Reconstr Surg 1966;38:581-583.
81. Amberg JR: A hazard of silicone foam diagnostic enema: report of a case of perforation of the colon. Am J Roentgen 1967;99:96-97.
82. Gurdin M, Carlin GA: Complications of breast implantations. Plast Reconstr Surg 1967;40:530-533.
83. Rees T, Ballantyne DL, Seidman I, Hawthorne GA: Visceral response to subcutaneous and intraperitoneal injections of silicone in mice. Plast Reconstr Surg 1967;39: 402-410.
84. Wallace JR: Foreign body reaction to dimethylpolysiloxane (Silastic): report of case. J Am Dent Assoc 1967;75:172-173.
85. Karfik V, Smahel J: Subcutaneous silicone granuloma. Acta Chir Plast (Praha) 1968;10:328-332.
86. nd Congress, second session, December 31, 1992, pp 3-4.
87. Rees TD, Ashley FL: Treatment of facial atrophy with liquid silicone. Am J Surg 1966;111:531-535.
88. Berger RA: Dermatologic experience with liquid silicones. NY State J Med 1966;66:2523-2526.
89. Rees TD, Ballantyne DL, Hawthorne GA: Silicone fluid research; a follow-up summary. Plast Reconstr Surg 1970;46:50-56.
90. Frey CF, Thorpe C, Brody G: Silicone fluid in the prevention of intestinal adhesions. Arch Surg 1967;95:253-256.
91. Brody GL, Frey CF: Peritoneal response to silicone fluid; a histologic study. Arch Surg 1968;96: 237-241.
92. st Congress, second session, December 18, 1990, p 104.
93. Nevada Statute 202.248: Crimes against public health and safety, 1975, p 120.
94. Franz FP: Massive injection of liquid silicone for hemifacial atrophy. Ann Plast Surg 1988;20: 140-145.
95. Le Van P: The causes and prevention of poor cosmetic results from injection of fluid silicone. J Dermatol Surg Oncol 1978;4:328-332.
96. 21 U.S.C. 360(c).
97. Federal Register 55, #96, May 17, 1990, pp 20,570.
98. Federal Register 53, #122, June 24, 1988, pp 23,856-23,877.
99. th Congress, first session, August 1, 1995, p 77.
100. Fisher AA: Reactions at silicone-injected sites on the face associated with silicone breast implant "inflammation" or "rejection." Cutis 1990;45:393-395.
101. Gutierrez FJ, Espinoza LR: Progressive systemic sclerosis complicated by severe hypertension: reversal after silicone implant removal. Am J Med 1990;89: 390-392.
102. Gylbert L, Asplund O, Jurell G: Capsular contracture after breast reconstruction with silicone-gel and saline-filled implants: a 6-year follow-up. Plast Reconstr Surg 1990;85:373-377.
103. Kaiser W, Biesenbach G, Stuby U, Grafinger P, Zazgornik J: Human adjuvant disease: remission of silicone induced autoimmune disease after explantation of breast augmentation. Ann Rheumat Dis 1990; 49:937-938.
104. Marik PE, Kark AL, Zambakides A: Scleroderma after silicone augmentation mammoplasty: a report of 2 cases. S Afr Med J 1990;77:212-213.
105. Hammer M, Krippner H: Three cases of chronic polyarthritis after silicone implantation (breast augmentation): causal relationship? Immun Infekt (Germany) 1991; 19:62-63.
106. Hitoshi S, Ito Y, Takehara K, Fujita T, Ogata E: A case of malignant hypertension and scleroderma after cosmetic surgery. Jpn J Med (Japan) 1991;30:97-100.
107. Kurisaki E, Mizusawa I, Hiraiwa K, Sato M: A rare fatal case of silicone resin precursor (SH792) poisoning. Am J Foren Med Pathol 1991;12:54-58.
108. Lazar AP, Lazar P: Localized morphea after silicone gel breast implantation: more evidence for a cause-and-effect relationship. Arch Dermatol 1991;127:263 (Letter).
109. Olesen LL, Ejfertsen T, Nielsen J: Toxic shock syndrome following insertion of breast prostheses. Br J Surg 1991;78:585-586.
110. Pegues DA, Shirley LA, Riddle CF, Anderson RL, Vess RW, Hill BC, Jarvis WR: Serratia marcescens surgical wound infection following breast reconstruction. Am J Med 1991;91:173S-178S.
111. Vasey FR, Espinoza LR, Martinez-Osuna P, Seleznick MJ, Brozena SJ, Penske NA: Silicone and rheumatic disease: replace implants or not? Arch Dermatol 1991;127:907 (Letter).
112. Warner E, Lipa M, Pearson D, Wenzel HA: Silicone mastopathy mimicking malignant disease of the breast in southeast Asian patients. Can Med Assoc J 1991; 144:569-571.
113. Williams CW: Silicone gel granuloma following compressive mammography. Aesth Plast Surg 1991; 15:49-51.
114. (Texas) Chronicle, November 7, 1996; February 3, 1997, and February 7, 1997.
115. The Daily Oklahoman (Oklahoma City, Oklahoma), July 27, 1996; November 14, 1995; March 6, 1996; and July 20, 1996.
116. Cocke WC, Leathers HK, Lynch JB: Foreign body reactions to Polyurethane covers of some breast prostheses. Plast Reconstr Surg 1975;56:527-530.
117. Smahel J: Tissue reactions to breast implants coated with polyurethane. Plast Reconstr Surg 1978;61:80-85.
118. Picha GJ, Goldstein JA, Stohr E: Natural-Y Meme polyurethane versus smooth silicone: analysis of the soft tissue interaction from 3 days to 1 year in the rat animal model. Plast Reconsir Surg 1990; 85:903-916.
119. Caffee HH, Hathaway C: Polyurethane foam-covered implants and capsular contracture: a laboratory investigation. Plast Reconstr Surg 1990;86:708-710.
120. Handel N, Silverstein MJ, Jensen JA, Collins A, Zierk F: Comparative experiences with smooth and polyurethane breast implants using the Kaplan-Meier method of survival analysis. Plast Reconstr Surg 1991;88:475-481.
121. Harmon KM: Silicon and boron; in JA Cambell, (ed): Chemical systems; Energetics, Dynamics, Structure, San Francisco, WH Freeman, 1970, p 639.
122. West R: Isolable compounds containing a silicon-silicon double bond. Science 1984;225:1109-1114.
123. Curl RF, Smalley RE: Fullerenes. Sci Am 1991;265:4:54-63.
124. Smalley RE: Great balls of carbon. The Sciences 1991;31:2:22-28.
125. Corriu RJP: Hypervalent species of silicon: structure and reactivity; in Bassindale AR, Gaspar, PP (eds): Frontiers of Organosilicon Chemistry. Cambridge, UK, Royal Society of Chemistry, 1991, pp 185-196.
126. Johnson SE, Deiters JA, Day RO, Holmes RB: Novel hydrolysis pathways of dimesityldifluorosilane via an anionic five-coordinated silicate and a hydrogen-bonded bisilonate: model intermediates in the sol-gel process. J Am Chem Soc 1989;111:3250-3258.
127. Farnham WB, Whitney JF: Stereo-mutation at hexacoordinate silicon by a ligand dissociation process. J Am Chem Soc 1984;106:3992-3994.
128. Norman NC: Periodicity and the P-Block Elements. Oxford, UK, Oxford University Press, 1994. pp 53,65.
129. Griffen DT: Silicate crystal chemistry. Oxford, UK, Oxford University Press, 1992, pp 3-15.
130. Schumann, W: Handbook of rocks, minerals and gemstones, Boston MA, Houghton Mifflin, 1993, p 36.
131. Ziskind M, Jones RN, Weill H: Silicosis. Am Rev Resp Dis 1976; 113:643-665.
132. Holleman, AF.: Handbook of chemistry, first part; in Inorganic chemistry, Wiberg E (ed) Berlin, Germany, 1951, Walterde Gruyter, pp 317-320 (in German).
133. Fessenden RJ, Fessenden JS: The biological properties of silicon compounds. Adv Drug Res 1967; 4:95-132.
134. Bergna HE, ed: The Colloid Chemistry of Silica. Advances in Chemistry Series, No. 234, Washington, DC, American Chemical Society, 1994, 695 pp.
135. Iler RK: The Colloid Chemistry of Silica and Silicates. Ithaca NY, Cornell University Press, 1955, pp 3-17.
136. Iler RK: The Chemistry of Silica. New York, Wiley, 1979. pp 15-78, 174-179, 220-222.
137. King TH, Belt TH: The physiological and pathological aspects of silica. Physiol Rev 1938;18: 329-365.
138. Silicosis and Silicate Disease Committee: diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med 1988;112:673-720.
139. Fallon JT, Banting FG: The cellular reaction to silica. Can Med Assoc J 1935;33:404-407.
140. Fallon JT, Banting FG: Tissue reaction to sericite. Can Med Assoc J 1935:33:407-411.
141. Schumann W: Handbook of Rocks, Minerals and Gemstones, Boston, MA, Houghton Mifflin, 1993, p 46.
142. Jones WR: Silicotic lungs: the minerals they contain. J Hyg 1933; 23:307-329.
143. Agricola G: De re Metallica. (Translated 1912 by Hoover HC and Hoover LH) New York, Dover Publications, 1950, p 214.
144. Pancoast HK, Pendergrass EP: Pneumoconiosis (silicosis); in Roentgenological Study with Notes in Pathology. New York, Paul B. Hoeber, 1926.
145. Cherniack M: The Hawk's Nest Incident: America's Worst Industrial Disaster. New Haven, Yale University Press, 1986, p 194.
146. Chapman EM: Acute silicosis. J Am Med Assoc 1932;98.1439-1441.
147. Nadler S, Goldfischer S: The intracellular release of lysosomal contents in macrophages that have injested silica. J Histochem Cytochem 1970;18:368-371.
148. Harington JS: Some biological actions of silica: their part in the pathogenesis of silicosis. S Afr Med J 1963:37:451-456.
149. Goldsmith S, Kopeloff A: Use of polarized-light microscopy as an aid in the diagnosis of silicosis. New EngI J Med 1961;265: 233-235.
150. Irwin DA: Microincineration as an aid in the diagnosis of silicosis. Can Med Assoc J 1934;31:140-143.
151. Millard DR, Maisels DO: Silicon granuloma of the skin and subcutaneous tissues. Am J Surg 1966; 112:119-123.
152. Wolman M: On the use of polarized light in pathology. Pathol Ann 1970;5:381-416.
153. McDonald JW, Roggli VL: Detection of silica particles in lung tissue by polarizing light microscopy. Arch Pathol Lab Med 1995; 119: 242-246.
154. Silicosis and silicate disease committee: Diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med 1988;112:685,701,715.
155. Knopf A: Quantitative determination of quartz (free silica) in dust. Pub Health Rep 1933;48:183-190.
156. Shanklin DR, Smalley DL: Microscopic technics and histologic findings in silicone mammary implant capsules and regional paranodal tissues. Curr Top Microbiol Immunol 1996;210:253-261.
157. Shanklin DR: Late tissue reactions to silicone and silica: the natural history of silicone-associated diseases with special reference to infections and immunological markers in tissue; in U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Silicone in Medical Devices, HHS Publication FDA 92-4249, Rockville, MD, 1991, pp 103-125.
158. Kasper CS, Chandler PJ: Talc deposition in skin and tissues surrounding silicone gel-containing prosthetic devices. Arch Dermatol 1994;130:48-53.
159. Eiseman B, Seelig MG, Womack NA: Talcum powder granuloma: a frequent and serious postoperative complication. Ann Surg 1947; 126: 820-832.
160. Tolbert TW, Brown JL: Surface powders on surgical gloves. Arch Surg 1980;115:729-732.
161. Khan MA, Brown JL, Logan KV, Hayes RI: Suture contamination by surface powders on surgical gloves. Arch Surg 1983;118: 738-739.
162. Antopol W: Lycopodium granuloma; its clinical and pathologic significance together with a note on granuloma produced by talc. Arch Pathol 1933;16:326-331.
163. Owen M: Peritoneal response to glove powder. Texas St J Med 1936;32:482-485.
164. Fienberg R: Talcum powder granuloma. Arch Pathol 1937; 24:36-42.
165. Molnar JJ, Nathanson G, Edberg S: Fatal aspiration of talcum powder by a child. N Engl Med 1962; 266:36-37.
166. Anani PA, Ribaux C, Gardiol D: Unusual intestinal talcosis. Am J Surg Pathol 1987;11:890-894.
167. Henderson WJ, Melville-Jones C, Barr WT, Griffiths K: Identification of talc on surgeons' gloves and in tissue from starch granulomas. Br J Surg 1975;62: 941-944.
168. Henderson WJ, Maskell AV, Griffiths K: Contamination of surgical gloves. Br Med J 1978;1:363.
169. Henderson WJ, Chandler JA, Blundell G, Griffiths K, Davies J: The application of analytical electron microscopy to the study of diseased biological tissue. J Microscopy (Oxford) 1973;99:183-192.
170. Schumann W: Handbook of Rocks, Minerals and Gemstones. Boston, MA, Houghton Mifflin, 1993, p 84.
171. nd ed, London, UK, Academic, 1977, pp 273-341.
172. Sweatman TR, Long JVP: Quantitative electron-probe microanalysis of rock-forming minerals. J Petrol 1969;10:332-379.
173. Thompson SA, Raisbeck MJ: Cardio-pericardiopexy; the surgical treatment of coronary arterial disease by the establishment of adhesive pericarditis. Ann Intern Med 1942;16:495-520.
174. Saxen A, Tuovinen PI: Experimental and clinical observations on granulomas caused by talc and some other substances. Acta Chir Scandinav 1947;96:131-151.
175. Thompson SA, Plachta A: Fourteen years' experience with cardiopexy in the treatment of coronary artery disease. J Thorac Surg 1954; 27:64-72.
176. Mazel MS: Persistence of new vascular channels following cardiopericardiopexy. J Am Med Assoc 1955;158:36-37.
177. English GL: Getting Acquainted with Minerals. New York, McGraw-Hill, 1934, pp 241-243.
178. Price EW: The pathology of non-filarial elephantiasis of the lower legs. Trans Roy Soc Trop Med Hyg 1972;66:150-159.
179. Heather CJ, Price EW: Non-filarial elephantiasis in Ethiopia; analytical study of inorganic material in lymph nodes. Trans Roy Soc Trop Med Hyg 1972;66:450-458.
180. Price EW, Henderson WJ: Silica and silicates in femoral lymph nodes of barefooted people in Ethiopia with special reference to elephantiasis of the lower legs. Trans Roy Soc Trop Med Hyg 1979;73: 640-647.
181. Haustein UF, Ziegler V, Herrmann K, Mehlhorn J, Schmidt C: Silica-induced scleroderma. J Am Acad Dermatol 1990;22:444-448.
182. Osorio AM, Thun MJ, Novak RF, Van Cura EJ, Avner ED: Silica and glomerulonephritis: case report and review of the literature. Am J Kid Dis 1987:9:224-230.
183. U.S. House of Representatives, 74th Congress, Second Session, House Joint Resolution 449, January 16, 17, 20-22, 27-29 and February 4, 1936, U.S. Government Printing Office, 1936, p. 203.
184. Sampson HL: The roentgenogram in so-called "acute" silicosis. Am J Pub Health 1933;23:1237-1239.
185. Gardner LU: Pathology of so-called acute silicosis. Am J Pub Health 1933;23:1240-1249.
186. Smith CS, Wikoff HL: The silica content of the lungs of a group of tunnel workers. Am J Pub Health 1933;23:1250-1254.
187. Ritterhoff RJ: Acute silicosis; occurring in employees of abrasive soap powder industries. Am Rev Tuberc 1941;43:117-131.
188. Caldwell DM: The coalescent lesion of diatomaceous earth pneumoconiosis. Am Rev Tuberc Dis 1958;77:644-661.
189. Dutra FR: Diatomaceous earth pneumoconiosis. Arch Environ Health 1965;11:613-619.
190. Beskow R: Silicosis in diatomaceous earth factory workers in Sweden. Scand J Resp Dis 1978; 59:216-221.
191. Vitums VC, Edwards MJ, Borman JO, Niles NR, Lowry RD: Pulmonary fibrosis from amorphous silica dust, a product of silica vapor. Arch Environ Health 1977;32: 62-68.
192. Philippou S, Teschler H, Morgenroth K: Lungenfibrose durch Inhalation von amorpher Kieselsaure. Zentralbl Pathol 1992; 138:41-46.
193. Shanklin DR, Smalley DL, Hall MF, Stevens MV: T cell-mediated immune response to silica in silicone implant patients. Curr Topics Microbiol Immunol 1996;210: 227-236.
194. Sommerville J, Milne JA: Pseudotuberculoma silicoticum. Br J Dermatol 1950;62:105-108.
195. Epstein E: Silica granuloma of the skin. AMA Arch Dermatol 1955; 71:24-25.
196. Crossland PM: Silcon granuloma of the skin. AMA Arch Dermatol 1955;71:457-461.
197. Forman L, Shuttleworth CW: Chronic granuloma of the gum with swelling of the lip in a patient handling sodium silicate solution. Proc Roy Soc Med 1956;49: 815-818.
198. Jones RN, Turner-Warwick M, Ziskind M, Weill H: High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis 1976;113:393-395.
199. Kunkel SL, Driscoll K, Ward PA, Nickoloff BJ, Stricter RM, Mediators of inflammation; in Craighead JE, (ed): Pathology of Environmental and Occupational Disease, St. Louis, Mosby, 1995, pp 385-395.
200. Gardner LU: The similarity of the lesions produced by silica and by the tubercle bacillus. Am J Pathol 1937:13:13-23.
201. Heppleston AG: The fibrogenic action of silica. Br Med Bull 1969; 25:282-287.
202. Allison AC, Harington JS, Birbeck M: An examination of the cytotoxic effects of silica on macrophages. J Exp Med 1966;124: 141-154.
203. Kolb-Bachofen V.: Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition. J Clin Invest 1992;90:1819-1824.
204. Ghiringhelli L, Pernis B: Augmento della produzione di anticorpi nei conigli trattati con tridimite per via endovenosa. Med Lavoro 1958; 49:665-671.
205. Pernis B, Paronetto F: Adjuvant effect of silica (tridimite) on antibody production. Proc Soc Exp Biol Med 1962;110:390-391.
206. Spitznagel JK, Allison AC: Mode of action of adjuvants: retinol and other lysosome-stabilizing agents as adjuvants. J Immunol 1970; 104:119-127.
207. Mancino D, Bevilacqua N: Adjuvant effects of amorphous silica on the immune response to various antigens in guinea pigs. Inter Arch Allergy Appl Immunol 1977;53: 97-103.
208. McHugh NJ, Whyte J, Harvey G, Haustein UF: Anti-topoisomerase I antibodies in silica-associated systemic sclerosis: a model for autoimmunity. Arthritis Rheumat 1994;37:1198-1205.
209. Catoggio LJ, Bernstein RM, Black CM, Hughes GRV, Maddison PJ: Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheumat Dis 1983; 42:23-27.
210. Roumm AD, Whitside TL, Medsger TA, Rodnam GP: Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations. Arthritis Rheumat 1984;27:645-653,.
211. Abraham D, Lupoli S, McWhirter A, Plater-Zyberk C, Piela TH, Korn JH, Olsen I, Black C: Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheumat 1991; 34: 1164-1172.
212. Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A: Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheumat Dis 1993;52:534-538.
213. Bramwell B: Diffuse scleroderma: its frequency, its occurrence in stone masons, its treatment by fibrolysis: elevation of temperature due to fibrolysin injection. Edinburgh Med J 1914;12:347-401.
214. Rustin MHA, Bull HA, Ziegler V, Mehlhorn J, Haustein U-F, Maddison PJ, James J, Dowd PM: Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol 1990;123: 725-734.
215. Li W, Kumar RK, O'Grady R, Velan GM: Role of lymphocytes in silicosis: regulation of secretion of macrophage-derived mitogenic activity for fibroblasts. Int J Exp Pathol 1992;73:793-800.
216. Smalley DL, Shanklin DR, Hall MF, Stevens MV: Immunologic stimulation of T lymphocytes by silica after use of silicone mammary implants. FASEB J 1995;9:424-427.
217. Refojo MF: Description and characteristics of different silicones including the presence of silica as a filler; in U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Silicone in Medical Devices, HHS Publication FDA 92-4249, Rockville, MD, 1991, pp 25-37.
218. Varga J, Schumacher HR, Jimenez SA: Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 1989;111:377-383.
219. Vojdani A, Campbell A, Brautbar N: Immune functional impairment in patients with clinical abnormalities and silicone breast implants. Toxicol Indust Health 1992;8: 415-428.
220. Bridges AJ, Conley C, Wang G, Burns DE, Vasey FR: A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med 1993; 118: 929-936.
221. Freundlich B, Altman C, Sandorfi N, Greenberg M, Tomaszewski J: A profile of symptomatic patients with silicone breast implants: A Sjögren's-like syndrome. Sem Arthritis Rheumat 1994;24:44-53.
222. Solomon G: A clinical and laboratory profile of symptomatic women with silicone breast implants. Sem Arthritis Rheumat 1994;24:29-37.
223. Smalley DL, Hall MF, Shanklin DR, Stevens MV: Immunologic markers in silicone breast implant recipients. Int J Occup Med Toxicol 1995;4:147-153.
224. Bar-Meir E, Teuber SS, Lin HC, Alosacie I, Goddard G, Terybery J, Barka N, Shen B, Peter JB, Blank M, Gershwin ME, Shoenfeld Y: Multiple autoantibodies in patients with silicone breast implants. J Autoimmun 1995;8: 267-277.
225. Bridges AJ, Anderson JD, Burns DE, Kemple K, Kaplan JD, Lorden T: Autoantibodies in patients with silicone implants. Curr Topics Microbiol Immunol 1996;210: 275-282.
226. Vojdani A, Brautbar N, Campbell N: Laboratory tests in aid for diagnosis of silicone induced immunologic disorders: A review. J Occup Med Toxicol 1994;3:1-19.
227. Claman HN, Robertson AD: Antinuclear antibodies and breast implants. West J Med 1994;160: 225-228.
228. Steenland K, Goldsmith DF: Silica exposure and autoimmune diseases. Am J Indust Med 1995;28: 603-608.
229. Hyde JF: Chemical background of silicones. Science 1965;147: 829-836.
230. Braley S: The chemistry and properties of the medical-grade silicones. J Macromol Sci Chem 1970; A4:529-544.
231. Bischoff F: Organic polymer biocompatibility and toxicology. Clin Chem 1972;18:869-894.
232. Frisch E: Silicone chemistry and pharmacokinetics; in U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Silicone in Medical Devices, HHS Publication FDA 92-4249, 1991, pp 7-23.
233. Annelin RB: Trace analysis of organosilicon in human urine and milk. Dow Corning Toxicology Department File 3135-1, May 29, 1980.
234. Koerner G, Schulze M, Weis J: Silicones: Chemistry and Technology, Boca Raton, FL, CRC, 1991, p 125.
235. Tomanek A: Silicones and Industry, Munich, Hanser/Wacker-Chemie, 1991, p 172.
236. Zeigler JM, Fearon FEG (eds): Silicon-Based Polymer Science; in Advances in Chemistry Series, No. 224, Washington, DC, American Chemical Society, 1990, 801 pp.
237. Bassindale AR, Gaspar PP (eds): Frontiers of Organosilicon Chemistry. Cambridge, UK, The Royal Society of Chemistry, 1991, 410 pp.
238. Barrett DM, O'Sullivan DC, Malizia AA, Reiman HM, Abell-Aleff PC: Particle shedding and migration from silicone genitourinary prosthetic devices. J Urol 1991;146:319-322.
239. Greenland S, Finkle WD: A case-control study of prosthetic implants and selected chronic diseases. Ann Epidemiol 1996;6:530-540.
240. Henderson J, Culkin D, Mata J, Wilson M, Venable D: Analysis of immunological alterations associated with testicular prostheses. J Urol 1995;154:1748-1751.
241. Naidu SH, Berediklian P, Adler L, Bora FW, Baker DG: In vivo inflammatory response to silicone elastomer particulate debris. J Hand Surg 1996;21A;496-500.
242. Smith DJ, Sazy JA, Crissman JD, Niu X-T, Robson MC, Heggers JP: Immunogenic potential of carpal implants. J Surg Res 1990;48:13-20.
243. Travis WD, Balogh K, Wolf BC, Doos WG, Abraham JL: Silicone-induced endocarditis. Arch Pathol Lab Med 1986;110:51-54.
244. Bernstein SA, Strickland RW, Lazarus E: Axillary lymphadenopathy due to Swanson implants. J Rheumatol 1993;20:1066-1069.
245. Reinberg Y, Manivel JC, Gonzalez R: Silicone shedding from artificial urinary sphincter in children. J Urol 1993;150:694-696.
246. Albores-Saavedra J, Vuitch F, Delagdo R, Wiley E, Hagler H: Sinus histiocytosis of pelvic lymph nodes after hip replacement; a histiocytic proliferation induced by cobalt-chromium and titanium. Am J Surg Pathol 1994; 18:83-90.
247. Bauer TW, Saltarelli M, McMahon JT, Wilde AH: Regional dissemination of wear debris from a total knee prosthesis. J Bone Joint Surg 1993;75-A:106-111.
248. Jirakawa K, Bauer TW, Culver JE, Wilde AH: Isolation and quantitation of debris particles around failed silicone orthopedic implants. J Hand Surg 1996;21 A:819-827.
249. Roux SP, Bertucci GM, Ibarra JA, Blatt G, Ashworth CR: Unilateral axillary adenopathy secondary to a silicone wrist implant: report of a case detected at screening mammography. Radiology 1996;198: 345-346.
250. Christie AJ, Weinberger KA, Dietrich M: Silicone lymphadenopathy and synovitis; complications of silicone elastomer finger joint prostheses. J Am Med Assoc 1977;237:1463-1464.
251. Shereff MJ, Jahss MH: Complications of silastic implant arthroplasty in the hallux. Foot Ankle 1980;1:95-101.
252. Fontana R, Talamonti G, D'Angelo V, Arena O, Monte V, Collice M: Spontaneous haematoma as unusual complication of silastic dural substitute: report of 2 cases. Acta Neurochir (Wien) 1992; 115: 64-66.
253. Ohbayashi N, Inagawa T, Katoh Y, Jumano K, Nagasako R, Hada H: Complication of silastic dural substitute 20 years after dural plasty. Surg Neurol 1944;41:338-341.
254. Brawer AE: Chronology of systemic disease development in 300 symptomatic recipients of silicone gel-filled breast implants. J Clean Technol Environ Toxicol Occup Med 1996;5:223-233.
255. Brawer AE: Clinical features of local breast phenomena in 300 symptomatic recipients of silicone gel-filled breast implants. J Clean Technol Environ Toxicol Occup Med 1996;5:235-247.
256. Ericsson AD: Syndromes associated with silicone breast implants: a clinical study and review. J Nutr Environ Med 1998;8:35-51.
257. Colin M, Borenstein D, Espinoza L, Silverman S, Solomon G: Analysis of preliminary operational criteria for systemic silicone related disease (SSRD). Arthritis Rheumat 1996;39:S51, Abst. 147.
258. Silverman S, Borenstein D, Solomon G, Espinoza L, Colin M: Preliminary operational criteria for systemic silicone related disease (SSRD). Arthritis Rheumat 1996; 39:551 (Abstr 148).
259. Vojdani A, Brautbar N, Campbell A: Immunologic and biologic markers for silicone. J Toxicol Indust Health 1994;10:25-42.
260. Vasey FB, Havice DL, Bocanegra TS, Seleznick MJ, Bridgeford PH, Martinez-Osuna P, Espinoza LR: Clinical findings in symptomatic women with silicone breast implants. Sem Arthritis Rheumat 1994;24:22-28.
261. Stott-Kendall P, Griffith D: Atypical rheumatic diseases and silicone breast implants workshop. Summary release, NIH, April 17, 1997.
262. Levine AM: Critique of premarket application. Silicone breast implant team leaders' report, Surgery Device Panel, Food and Drug Administration, February 9, 1993, Washington, DC, pp 42-52.
263. Dow Corning Corporation, Product Return Records 13.04.40, September 13, 1989, p 33.
264. Bachman v. Medical Engineering Corporation, et al., United States District Court, Western District of Washington (State), Civil Action 86-143TB.
265. deCamara DL, Sheridan JM, Kammer BA: Rupture and aging of silicone gel breast implants. Plast Reconstr Surg 1993;91:828-834.
266. Robinson GO, Bradley EL, Wilson DS: Analysis of explanted silicone implants: a report of 300 patients. Ann Plast Surg 1995; 34:1-7.
267. Goldberg EP, Widenhouse C, Marotta J, Martin P: Failure of silicone gel breast implants: analysis of literature data for 1652 explanted prostheses. Plast Reconstr Surg 1997;100:281-284.
268. Goldberg EP: Silicone gel breast implant failure and frequency of additional surgeries from examination of more than 8000 explants. IOM Committee on the Safety of Silicone Breast Implants, National Academy of Sciences, Washington, DC, July 24, 1998.
269. Brown SL, Silverman BG, Berg WA: Factors affecting the rupture of silicone-gel breast implants. Lancet 1997;350:1531-1537.
270. Peters W, Keystone E, Smith D: Factors affecting the rupture of silicone-gel breast implants. Ann Plast Surg 1994;32:449-451.
271. Nosanchuk JS: Silicone granuloma in breast. Arch Surg 1968; 97:583-585.
272. Travis WD, Balogh K, Abraham JL: Silicone granulomas: report of three cases and review of the literature. Hum Pathol 1985:16:19-27.
273. Marques AF, Brenda E, Saldiva PHN, Andrews JM: Capsular hematoma as a late complication in breast reconstruction with silicone gel prostheses. Plast Reconstr Surg 1992;89:543-545.
274. Xue N, Mombello GE, Carter D: Formation of a neoimplant after removal of a silicone gel-filled breast implant. Pathology Case Rev 1996;1:32-35.
275. Solomons ET, Jones JK: The determination of polydimethylsiloxane (silicone oil) in biological materials: A case report. J Forensic Sci 1975;20:191-199.
276. Ellenbogen R, Ellenbogen R, Rubin L: Injectable fluid silicone therapy; human morbidity and mortality. J Am Med Assoc 1975; 234:308-309.
277. McCurdy HH, Solomons ET: Forensic examination of toxicological specimens for dimethylpolysiloxane (silicone oil). J Anal Toxicol 1977;1:221-223.
278. Delage C, Shane JJ, Johnson FB: Mammary silicone granuloma. Arch Dermatol 1973;108:104-107.
279. Rich JD, Shesol BF, Gottlieb V: Supraclavicular migration of breast-injected silicone: case report. Milit Med 1982;147: 404-405.
280. Ortiz-Monasterio F, Trigos I: Management of patients with complications from injections of foreign materials into the breasts. Plast Reconstr Surg 1972:50:42-47.
281. Huang TT, Blackwell SJ, Lewis SR: Migration of silicone gel after the "squeeze technique" to rupture a contracted breast capsule. Plast Reconstr Surg 1978;61:277-280.
282. Foster WC, Springfield DR, Brown KLB: Pseudotumor of the arm associated with rupture of silicone-gel breast prostheses. J Bone Joint Surg 1983;65A:548-551.
283. Capozzi A, DuBou R, Pennisi VR: Distant migration of silicone gel from a ruptured breast implant: case report. Plast Reconstr Surg. 1978;62:302-303.
284. Masson ChL, Dessapt B, Rochet M: Migration du gel de silicone apres rupture de prothese mammaire au cours d'une capsulotomie externe. Ann Chir Plast 1982; 27: 369-373.
285. Sanger JR, Kolachalam R, Komorowski RA, Yousif NJ, Maltouh HS: Silicone gel extravasation into the arm: a clinical and experimental correlation of the effect on the peripheral nerve; in U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Silicone in Medical Devices, HHS Publication FDA 92-4249, 1991, pp 69-76.
286. Sanger JR, Maltoub HS, Yousif NJ, Komorowski R: Silicone gel infiltration of a peripheral nerve and constrictive neuropathy following rupture of a breast prosthesis. Plast Reconstr Surg 1992; 89:949-952.
287. Liebman AJ, Kossoff MB, Kruse BD: Intraductal extension of silicone from a ruptured breast implant. Plast Reconstr Surg 1991:89:546-547.
288. Zide BM: Complications of closed capsulotomy after augmentation. Plast Reconstr Surg 1981;67:697.
289. Taupmann RE, Adler S: Silicone pleural effusion due to iatrogenic breast implant rupture. South Med J 1993;86:570-571.
290. Hirmand H, Hoffman LA, Smith JP: Silicone migration to the pleural space associated with silicone-gel augmentation mammaplasty. Ann Plast Surg 1994;32:645-647.
291. Teuber SS, Ito LK, Anderson M, Gershwin ME: Silicone breast implant-associated scarring dystrophy of the arm. Arch Dermatol 1995:131:54-56.
292. Argenta LC: Migration of silicone gel into breast parenchyma following mammary prosthesis rupture. Aesth Plast Surg 1983;7:253-254.
293. Celli B, Textor S, Kovnat DN: Case report: adult respiratory distress syndrome following mammary augmentation. Am J Med Sci 1978:275:81-85.
294. Shoaib BO, Patten BM, Calkins DS: Adjuvant breast disease: an evaluation of 100 symptomatic women with breast implants or silicone fluid injections. Keio J Med 1994;43:79-87.
295. Kulber DA, Mackenzie D, Steiner JH, Glassman H, Hopp D, Hiatt JR, Hoffman L: Monitoring the axilla in patients with silicone gel implants. Ann Plast Surg 1995;35: 580-584.
296. Janson RA: Implant arm:axillary compression from breast prostheses. Plast Reconstr Surg 1985;75: 420-422.
297. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ: Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994:330:1697-1702.
298. Edworthy SM, Martin L, Barr SG, Birdsell DC, Brant RF, Fritzler FJ: A clinical study of the relationship between silicone breast implants and connective tissue diseases. J Rheumatol 1998;25:254-260.
299. Shanklin DR, Smalley DL: Additional surgery after breast device implantation. J Rheumatol 1998; 25:2474 (Letter).
300. Wustrack KO, Zarem HA: Surgical management of silicone mastitis. Plast Reconstr Surg 1979;63: 224-229.
301. Kabalin JN, Kessler R: Penile prosthesis surgery: review of ten-year experience and examination of reoperations. Urology 1989;33: 17-19.
302. Baker JL, Barteis RJ, Douglas WM: Closed compression technique for rupturing a contracted capsule around a breast implant. Plast Reconstr Surg 1976;58:137.
303. Williams C, Aston S, Rees TD: The effect of hematoma on the thickness of pseudosheaths around silicone implants. Plast Reconstr Surg 1975;58:194-198.
304. Vinnik CA: Spherical contracture of fibrous capsules around breast implants. Plast Reconstr Surg 1976; 58:555-560.
305. Orneal RM: High-pressure injection of silicone gel into an axilla - a complication of closed compression capsulatomy of the breast. Plast Reconstr Surg 1979; 63:700-707.
306. Harvey SC: The healing of the wound as a biologic phenomenon. Surgery 1949;25:655-671.
307. Domanskis EJ, Owsley JQ: Histological investigation of the etiology of capsule contracture following augmentation mammoplasty. Plast Reconstr Surg 1976;58:689-693.
308. Hausner RJ, Schoen FJ, Pierson KK: Foreign-body reaction to silicone gel in axillary lymph nodes after augmentation. Plast Reconstr Surg 1978;62:381-383.
309. Truong LD, Cartwright J, Goodman MD, Woznicki D: Silicone lymphadenopathy associated with augmentation mammaplasty. Am J Surg Pathol 1988;12:484-491.
310. Hausner RJ, Schoen F, Mendez-Fernandez HA, Henly WS, Geis RC: Migration of silicone gel to axillary lymph nodes after prosthetic mammaplasty. Arch Pathol Lab Med 1981;105:371-372.
311. Mason J, Apisarnthanarax P: Migratory silicone granuloma. Arch Dermatol 1981;117:366-367.
312. Symmers WStC: Silicone mastitis in "topless" waitresses and some other varieties of foreign body mastitis. Br Med J 1968;3:19-22.
313. Wintsch W, Smahel J, Clodius L: Local and regional lymph node response to ruptured gel-filled mammary prostheses. Br J Plast Surg 1978;31:349-352.
314. Rosenau W, Moon HD: The inhibitory effect of hydrocortisone on lysis of homologous cells by lymphocytes in vitro. J Immunol 1962; 89:422-426.
315. Gray JG, Pratt WB, Aronow L: Effect of glucocorticoids on hexose uptake by mouse fibroblasts in vitro. Biochemistry 1971;10:277-284.
316. Cronstein BN, Kimmel SC, Levin RI, Martiniak I, Weissmann G: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992;89:9991-9995.
317. Robb RJ, Greene WC, Rusk CM: Low and high affinity cellular receptors for interleukin 2. J Exp Med 1984;160:1126-1146.
318. Smith KA: T-cell growth factor. Immunol Rev 1980:51:337-357.
319. Kasper CS: Histologic features of breast capsules reflect surface configuration and composition of silicone bag implants. Am J Clin Pathol 1994;102:655-659.
320. Silver RM, Sahn EE, Allen JA, Sahn S, Greene W, Maize JC, Garen PD: Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol 1993:129:63-68.
321. Schnur PL, Weinzweig J, Harris JB, Moyer TP, Petty PM, Nixon D, McConnell JP: Silicon analysis of breast and periprosthetic capsular tissue from patients with saline or silicone gel breast implants. Plast Reconstr Surg 1996;98: 798-803.
322. Xiao K, Appleby AJ: Physical and bioelectrochemical behavior of polydimethylsiloxanes in physiological electrolytes. J Clean Technol Environ Toxicol Occup Med 1996;5:249-257.
323. Christie AJ, Pierret G, Levitan J: Silicone synovitis. Sem Arthritis Rheumat 1989;19:166-171.
324. Lossing C, Hansson H-A: Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast Reconstr Surg 1993;91:1277-1286.
325. Dobke MK, Grzybowski J, Stein P, Landon BN, Dobak J, Parsons CL: Fibroblast behavior in vitro is unaltered by products of Staphylococci cultured from silicone implants. Ann Plast Surg 1994; 32:118-125.
326. McCauley RL, Riley WB, Juliano RA, Brown P, Evans MJ, Robson MC: In vitro alterations in human fibroblast behavior secondary to silicone polymers. J Surg Res 1990;49:103-109.
327. Picha GJ, Goldstein JA: Analysis of the soft tissue response to components used in the manufacture of breast implants: rat animal model. Plast Reconstr Surg 1991; 87:490-500.
328. Raso DS, Greene WB, Metcalf JS: Synovial metaplasia of a periprosthetic breast capsule. Arch Pathol Lab Med 1994;118:249-251.
329. Emery JA, Spanier SS, Kasnic G, Hardt NS: The synovial structure of breast-implant-associated bursae. Modern Pathol 1994;7:728-733.
330. Raso, DS, Crymes LW, Metcalf JS: Histological assessment of fifty breast capsules from smooth and textured augmentation and reconstruction mammoplasty prostheses with emphasis on the role of synovial metaplasia. Modern Pathol 1994;7:310-316.
331. Copeland M, Choi M, Bleiweiss IJ: Silicone breakdown and capsular synovial metaplasia in textured- wall saline breast implants. Plast Reconstr Surg 1994;94:628-633.
332. Chase DR, Oberg KC, Chase RL, Malott RL, Weeks DA: Pseudoepithelialization of breast implant capsules. Int J Surg Pathol 1994; 1:151-154.
333. Schnitt SJ: Tissue reactions to mammary implants: a capsule summary. Adv Anal Pathol 1995; 2:24-27.
334. Bleiweiss IJ, Copeland M: Capsular synovial metaplasia and breast implants. Arch Pathol Lab Med 1995;119:115 (Letter).
335. Raso DS, Greene WB: Capsular synovial metaplasia and breast implants. Arch Pathol Lab Med 1995;119:116 (Letter).
336. Hameed MR, Erlandson R, Rosen PP: Capsular synovial-like hyper-plasia around mammary implants similar to dentrilic synovitis. Am J Surg Pathol 1995;19:433-438.
337. del Rosario AD, Bui HX, Petrocine S, Sheenhan C, Pastore J, Singh J, Ross JS: True synovial metaplasia of breast implant capsules: a light and electron microscopic study. Ultrastruct Pathol I995;19:83-93.
338. Kossovsky N, Freiman CJ: Silicone breast implant pathology; clinical data and immunological consequences. Arch Pathol Lab Med 1994;118:686-693.
339. Dolwick MF, Aufdemorte TB: Silicone-induced foreign body reaction and lymphadenopathy after temporomandibular joint arthroplasty. Oral Surg Oral Med Oral Pathol 1985;59:449-451.
340. Kossovsky N, Stassi J: A pathophysiological examination of the biophysics and bioreactivity of siliconebreast implants. Sem Arthritis Rheumat 1994;24:18-21.
341. Wickham MG, Rudolph R, Abraham JL: Silicon identification in prosthesis-associated fibrous capsules. Science 1978;199:437-439.
342. Cabral AR, Alcocer-Varela J, Orozco-Topete R, Reyes E, Ferández-Dominguez L, Alarcón-Segovia D: Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils. Revist Invest Clin 1994;46: 257-266.
343. Raso DS, Greene WB, Vesely JJ, Willingham MC: Light microscopy techniques for the demonstration of silicone gel. Arch Pathol Lab Med 1994;118:984-987.
344. Roggli VL, McDonald JW, Shelburne JD: The detection of silicone within tissues. Arch Pathol Lab Med 1994;118:963-964 (Editorial).
345. Raso DS, Greene WB: Silicone breast implants: pathology. Ultrastruct Pathol 1997;21:263-271.
346. Vaamonde R, Cabrera JM, Vaamonde-Mart́n RJ, Jimena I, Mart́n JM: Silicone granulomatous lymphadenopathy and siliconomas of the breast. Histol Histopathol 1997;12:1003-1011.
347. Mandel MA, Gibbons DF: The presence of silicone in breast capsules. Aesth Plast Surg 1979;3: 219-225.
348. 348 Mark JE: Silicon-containing polymers; in Zeigler JM, Fearin FWG, (eds): Silicon-based polymer science. Washington, DC American Chemical Society, 1990, p 53-55.
349. Dillon ME: Silicone and poly-(tetrafluoroethylene) interpenetrating polymer networks; in Klempner D, Sperling LH, Utracki LA, (eds): Interpenetrating Polymer Networks. Washington, DC, American Chemical Society, 1994, p 398.
350. Thomsen JL, Christensen L, Nielsen M, Brandt B, Breiting VB, Felby S, Nielsen E: Histologic changes and silicone concentrations in human breast tissue surrounding silicone breast prostheses. Plast Reconstr Surg 1990; 85: 38-41.
351. McManus JFA, Mowry RW: Staining Methods; Histologic and Histochemical. New York, Paul D. Hoeber, 1960, pp 5-7, 67-69.
352. Kossovsky N, Millett DE, Wrobleski DA: Fourier transform infrared spectroscopic analysis of organic oil mastitis. Am J Clin Pathol 1992; 97:34-39.
353. Hardt NS, Yu LT, La Torre G, Steinbach B: Fourier transform infrared microspectroscopy used to identify foreign materials related to breast implants. Modern Pathol 1994;7:669-676.
354. Centeno JA, Johnson FB: Microscopic identification of silicone in human breast tissues by infrared microspectroscopy and x-ray microanalysis. Appl Spectrosc 1993;47: 341-345.
355. Frank CJ, McCreery RL, Redd DCB, Gansler TS: Detection of silicone in lymph node biopsy specimens by near-infrared Raman spectroscopy. Appl Spectrosc 1993; 47:387-390.
356. Cavic-Vlasak BA, Thompson M, Smith DC: Silicones and their determination in biological matrices, a review. Analyst 1996;212: 53R-63R.
357. 1H chemical shift imaging of silicone implants. Magnetic Reson Med 1993;29:656-659.
358. Garrido L, Pfleiderer B, Papisov M, Ackerman JL: In vivo degradation of silicones. Magnetic Reson Med 1993;29:839-843.
359. Pfleiderer B, Ackerman JL, Garrido L: Migration and biodegradation of free silicone from silicone gel-filled implants after long-term implantation. Magnetic Reson Med 1993:30:534-543.
360. Garrido L, Pfleiderer B, Jenkins BG, Hulka CA, Kopans DB: Migration and chemical modification of silicone in women with breast prostheses. Magnetic Reson Med 1994:31:328-330.
361. Pfleiderer B, Garrido L: Migration and accumulation of silicone in the liver of women with silicone gel-filled breast implants. Magnetic Reson Med 1995;33:8-17.
362. 2 (aerosil) and 2-mercaptoethanol or diethanolsulfide in the immunization and stimulation of spleen cell cultures. FEBS Letters 1980;118:212-214.
363. 2 and 2-mercaptoethanol. Immunol 1982;45:381-385.
364. Ueki A, Yamaguchi M, Ueki II, Watanabe Y, Ohsawa G, Kinugawa K, Kawakami Y, Hyodoh F: Polyclonal human T-cell activation by silicate in vitro. Immunol 1994;82:332-335.
365. Yoshino S: Silicone-induced arthritis in rats and possible role for T cells. Immunobiol 1994;192: 40-47.
366. Roggendorf E: The biostability of silicone rubbers, a polyamide, and a polyester. J Biomed Materials Res 1976;10:123-143.
367. Robertson JLA: Late deterioration of silicone rubber foam breast implants. Plast Reconstr Surg 1970; 62:793-795.
368. van Diest PJ: Pathology of silicone leakage from breast implants. J Clin Pathol 1998:51:493-497.
369. Epstein WL, Skahen JR, Krasnobrod H: The organized epithelioid granuloma: differentiation of allergic (zirconium) from colloidal (silica) types. Am J Pathol 1963: 43:391-405.
370. Epstein WL, Krasnobrod H: The origin of epithelioid cells in experimental granulomas in man. Lab Invest 1968:18:190-195.
371. Sanchez-Guerrero J, Schur PH, Sergent JS, Liang MH: Silicone breast implants and rheumatic disease; clinical, immunologic, and epidemiologic studies. Arthritis Rheumat 1994;37:158-168.
372. Sorrell CA: Rocks and Minerals. New York, Western Publishing, Golden Press, 1973, p 200,201.
373. m lymphocyte response to silica in fibromyalgia (FM). 8th Annual Conference of the International Society for Environmental Epidemiology, Edmonton, Alberta, Canada, August 17-21. Epidemiology 1996;7(4):T130.
374. Anderson JM: Inflammatory response to implants. Trans Am Soc Artif Intern Organs 1988;34: 101-107.
375. Abraham SN: Discovering the benign traits of the mast cell. Sci Med 1997;4:5:46-55.
376. Medzhitov R, Janeway CA: Innate immunity: the virtues of a nonclonal system of recognition. Cell 1996;91:295-298.
377. Vondracek P, Gent AN: Slow decomposition of silicone rubber. J Appl Polymer Sci 1982;27: 4517-4523.
378. Buch RR, Ingebrigtson DN: Rearrangement of poly(dimethylsiloxane) fluids on soil. Environ Sci Technol 1979;13:676-679.
379. Carpenter JC, Cell JA, Dorn SB: Study of the degradation of polydimethylsiloxanes on soil. Environ Sci Technol 1995;29:864-868.
380. Neu TR, Van der Mei HC, Busscher HJ, Dijk F, Vererke GJ: Biodeterioration of medical-grade silicone rubber used for voice prostheses: a SEM study. Biomaterials 1993:14:459-464.
381. McKinney P, Tresley G: Long-term comparison of patients with gel and saline mammary implants. Plast Reconstr Surg 1983;72: 27-31.
382. Barker DE, Retsky MI, Schultz S: "Bleeding" of silicone from bag-gel breast implants, and its clinical relation to fibrous capsule reaction. Plast Reconstr Surg 1978;61: 836-841.
383. Ferreira JA: The various etiological factors of "hard capsule" formation in breast augmentation. Aesth Plast Surg 1984;8:109-117.
384. Sabbagh WH, Murphy RX, Kucirka SJ, Okunski WJ: Idiosyncratic allergic reaction to textured saline implants. Plast Reconstr Surg 1996;97:820-823.
385. Becker H: The expandable mammary implant. Plast Reconstr Surg 1987:79:631-637.
386. Teuber SS, Howell LP, Yoshida SH, Gershwin ME: Remission of sarcoidosis following removal of silicone gel breast implants. Int Arch Allerg Immunol 1994;105: 404-407.
387. Bommer J, Ritz E, Waldherr R: Silicone induced splenomegaly. N Engl J Med 1981;305:1077-1078.
388. Leong AS-Y, Disney APS, Gove DW: Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis. N Engl J Med 1982;306:135-140.
389. Andrews JM: Cellular behavior to injected silicone fluid: A preliminary report. Plast Reconstr Surg 1866;38:581-583.
390. Smalley DL, Shanklin DR, Abell T, Hall MF. Anamnestic immune response to silica following reexposure in a mammary implant patient. 11th annual meeting of Southern Association of Clinical Microbiology, Nashville, TN, September 14-16, 1994 (abstract), SACM Review 1995;18:(1):12-13.
391. Kossovsky N, Heggers JP, Parsons RW, Robson MC: Acceleration of capsule formation around silicone implants by infection in a guinea pig model. Plast Reconstr Surg 1984;73:91-96.
392. Miller KM, Anderson JM: Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J Biomed Materials Res 1988;22:713-731.
393. Spilizewski KL, Marchant RE, Anderson JM, Hiltner A: In vivo leucocyte interactions with the NHLBI-DTB primary reference materials: polyethylene and silica-free polydimethylsiloxane. Biomaterials 1987;8:12-17.
394. Miller KM, Rose-Caprara V, Anderson JM: Generation of IL-1-like activity in response to bio-medical polymer implants: a comparison of in vitro and in vivo models. J Biomed Materials Res 1989; 23:1007-1026.
395. Bonfield TL, Colton E, Marchant RE, Anderson JM: Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J Biomed Materials Res 1992;26:837-850.
396. Bonfield TL, Anderson JM: Functional versus quantitative comparison of TL-1β from monocytes/ macrophages on biomedical polymers. J Biomed Materials Res 1993; 27:1195-1199.
397. Nairn JO, Lanzafame RJ, van Oss CJ: The effect of silicone-gel on the immune response. J Biomaterials Sci Polymer Edn 1995;7: 123-132.
398. Naim JO, Ippolito KML, van Oss CJ: Adjuvancy effect of different types of silicone gel. J Biomed Materials Res 1997;37:534-538.
399. Naim JO, Zhang JW, van Oss CJ: In vitro activation of human monocytes by various plasma proteins adsorbed onto silicone elastomers, gels and oils. Surfaces in Biomaterials Foundation, Phoenix, AZ, September 5-7, 1996, pp 104-106 (abstract).
400. Lukacs NW, Chensue SW, Smith RE, Strieter RM, Warmington K, Wilke C, Kunkel SL: Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α by inflammatory fibroblasts. Am J Pathol 1994; 144:711-718.
401. Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG: Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1989;1: 439-447.
402. Rosenstreich DL, Farrar JJ, Dougherty S: Absolute macrophage dependency of T lymphocyte activation by mitogens. J Immunol 1976;116:131-139.
403. Kossovsky N, Heggers JP, Robson MC: Experimental demonstration of the immunogenicity of silicone- protein complexes. J Biomed Materials Res 1987;21:1125-1133.
404. 4) enhances antibody production to bovine serum albumin. J Biomed Materials Res 1996;31:345-353.
405. Devereux DF, O'Connell SM, Liesch JB, Weinstein M, Robertson FM: Induction of leukocyte activation by meshes surgically implanted in the peritoneal cavity. Am J Surg 1991;162:243-246.
406. Landon BN, Dobke MK, Grzybowski J, Virden CP, Dobak J, Steinsapir ES: Enhanced activity of lysosomal β-galactosidase after silicone implantation: an experimental study in rats. J Lab Clin Med 1993:121:742-750.
407. Tang LP, Jennings TA, Eaton JW: Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Nat Acad Sci USA 1998;95:8841-8846.
408. Remes A, Williams DF: Immune response in biocompatibility. Biomaterials 1992;13:731-743.
409. Herrmann K, Schulze E, Haustein UF, Böhme HJ, Zeigler V: Origin of the enhanced activity of lysosomal beta-galactosidase in serum and skin in progressive systemic sclerosis. Arch Dermatol Res 1987; 279:299-302.
410. Young VL, Bartell T, Destouet JM, Monsees B, Logan SE: Calcification of breast implant capsule. South Med J 1989;82:1171-1173.
411. Rolland C, Guidoin R, Ledoux R, Zerguini A, Roy P-E: Carbonatehydroxylapatite, hopeite, and parascholzite in Fibrous capsules surrounding silicone breast implants. Can Mineralogist 1991; 29:337-345.
412. Peters W, Smith D: Calcification of breast implant capsules: incidence, diagnosis, and contributing factors. Ann Plast Surg 1995:34: 8-11.
413. Koide T, Katayama H: Calcification in augmentation mammoplasty. Radiology 1979;130:337-340.
414. Dodd LG, Sneige N, Reece GP, Fornage B: Fine-needle aspiration cytology of silicone granulomas in the augmented breast. Diagn Cytopathol 1993:9:498-502.
415. Freemont AJ: Molecules controlling lymphocyte-endothelial interactions in lymph nodes are produced in vessels of inflamed synovium. Ann Rheumat Dis 1987:46:924-928.
416. Kadiogly A, Sheldon P: Adhesion of rheumatoid peripheral blood and synovial fluid mononuclear cells to high endothelial venules of gut mucosa. Ann Rheumat Dis 1992;51:126-127.
417. Yanni G, Whelan A, Feighery C, Fitzgerald O, Bresnihan B: Morphometric analysis of synovial membrane blood vessels in rheumatoid arthritis: associations with the immunohistologic features, synovial fluid cytokine levels and the clinical course. J Rheumatol 1993; 20:634-638.
418. Henrotte JG, Viza D, Vich JM, Gueyne J: Le role regulateur du silicium la division cellulaire. CR Acad Sci Paris 1988;306:525-528.
419. Bedu O, Goy J, Rouffy J, Loeper J: Action of silicon on cultured lymphocytes. Med Sci Res 1991;19: 317-318.
420. Raso DS: Breast prostheses, the immune response, and B- and T- lymphocytes. Plast Reconstr Surg 1994;93:649-650.
421. Ojo-Amaize EA, Conte V, Lin HC, Brucker RF, Agopian MS, Peter JB: Silicone-specific blood lymphocyte response in women with silicone breast implants. Clin Diagn Lab Immunol 1994;1:689-695.
422. Yoshino S: Downregulation of silicone-induced chronic arthritis by gastric administration of type II collagen. Immunopharmacology 1995;31:103-108.
423. Smalley DL, Shanklin DR, Hall MF, Stevens MV: Detection of lymphocyte stimulation by silicon dioxide. Int J Occup Med Toxicol 1995;4:63-70.
424. Granchi D, Cavedagna D, Ciapetti G, Stea S, Cenni E, Guiliani P, Pizzoferrat A: Silicone breast implants: the role of immune system on capsular contracture formation. J Biomed Materials Res 1995; 29:197-202.
425. Ciapetti G, Granchi D, Stea S, Cenni E, Schiavon P, Guiliani R, Pizzoferrato A: Assessment of viability and proliferation of an in vivo silicone-primed lymphocytes after in vitro reexposure to silicone. J Biomed Materials Res 1995; 29:583-590.
426. Narini PP, Semple JL, Hay JB: Repeated exposure to silicone gel can induce delayed hypersensitivity. Plast Reconstr Surg 1995;96: 371-380.
427. Lawless OJ, Ojo-Amaize EA, Peter JB: Silicone-specific T-cell reactivity in saline breast implants and non-breast implant patients. Immunology of Silicones Workshop. National Institutes of Health, Bethesda, MD, March 1995, p 28 (Abstract).
428. O'Hanlon TP, Okada S, Love LA, Dick G, Young VL, Miller FW: Immunohistopathology and T cell receptor gene expression in capsules surrounding silicone breast implants. Curr Topics Microbiol Immunol 1996;210:237-242.
429. Katzin WE, Feng L-J, Abbuhl M, Klein MA: Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants. Clin Diagn Lab Immunol 1996;3:156-161.
430. Smalley DL, Shanklin DR: Dynamics of IL-2 receptor stimulation in T cells from patients with silicone toxicity. FASEB J 1997; 11:A536, (Abstract #3099).
431. Smalley DL, Shanklin DR, Hall ME: Requirement of monocyte presence for stimulation of T lymphocytes by silicon dioxide. FASEB J 1998;12:A489 (Abstract #2845).
432. McDonald AH, Svatek J, Schneider M, Sanger J: Silicone gel induces production of anti-dsDNA antibodies in New Zealand Black (NZB) mice. FASEB J 1998;12: A286 (Abstract #1669).
433. Ojo-Amaize EA, Lawless OJ, Peter JB: Elevated concentrations of interleukin-1β and interleukin-1 receptor antagonist in plasma of women with silicone breast implants. Clin Diagn Lab Immunol 1996; 3:257-259.
434. Smalley DL, Shanklin DR, Hall MF: Monocyte-dependent stimulation of human T cells by silicon dioxide. Pathobiol 1998;66: 302-305.
435. Shanklin DR, Peterson C, Smalley DL: Enhanced urinary silicate excretion in women with implanted silicone devices. FASEB J 1997; 11:A548 (Abstract #3170).
436. Drake CG, Kotzin BL: Superantigens: biology, immunology. and potential role in disease. J Clin Immunol 1992;12:149-162.
437. McCormack JE, Callahan JE, Kappler J, Marrack PC: Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 1993; 150:3785-3792.
438. Shanklin DR, Smalley DL: Time dependency of T cell memory after silicone device implantation and explantation. FASEB J 1998;12: A489 (Abstract #2845).
439. Goldblum RM, Pelley RP, O'Donell AA, Pyron D, Heggers JP: Antibodies to silicone elastomers and reaction to ventriculoperitoneal shunts. Lancet
440. Wolf LE, Lappé M, Peterson RD, Ezrailson EG: Human immune response to polydimethylsiloxane (silicone): screening studies in a breast implant population. FASEB J 1993;7:1265-1268.
441. Kossovsky N, Zeidler M, Chun G, Papasian N, Nguyen N, Rajguru S, Stassi J, Gelman A, Sponsler E: Surface dependent antigens indentified by high binding avidity of serum antibodies in a subpopulation of patients with breast prostheses. J Appl Biomaterials 1993; 4:281-288.
442. Scheel LD, Smith B, Van Riper J, Fleisher E: Toxicity of silica II. Characteristics of protein films adsorbed by quartz. AMA Arch Indust Hyg Occup Med 1954;9:29-36.
443. Tebbens BD, Schulz RZ, Drinker P: Potency of silica particles of different size. J Indust Hyg Toxicol 1945;27:199-200.
444. Gusev VA, Danilovskaja YV, Vatolkina OY, Lomonosova OS, Velichkovsky BT: Effect of quartz and alumina dust on generation of superoxide radicals and hydrogen peroxide by alveolar macrophages, granulocytes, and monocytes. Br J Indust Med 1993;50:732-735.
445. Smalley DL, Talcott TD, Shanklin DR: Response enhancement in T cell lymphocyte memory testing by triphasic combination of silicaceous mitogens. FASEB J 1996; 10:A1434 (Abstract #2503).
446. Tenenbaum SA, Rice JC, Espinoza LR, Cuéliar ML, Plymale DR, Sander DM, Williamson LL, Haislip AM, Gluck OS, Tesser JRP, Nogy L, Stribrny KM, Bevan JA, Garry RF: Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 1997; 349: 449-454.
447. Zazgornik J, Pizu H, Kaiser W, Bettelheim P, Steiner G, Smolen J, Biesenbach G, Maschek W: Autoimmune reactions in patients with silicone breast implants. Wien Klin Wochenschr 1996; 108: 781-787.
448. Press RI, Peebles CL, Kumagai Y, Ochs RL, Tan EM: Antinuclear autoantibodies in women with silicone breast implants. Lancet 1992; 340:1304-1307.
449. Shanklin DR, Dreiman RM, Hall MF, Smalley DL: Anablot band frequencies and clusters in patients with silicone mammary devices. South Med J 1998;91:S111.
450. Smalley DL, Hall MF, Broughton CL: Autoantibodies present in chronic hepatitis C and chronic hepatitis B viral infections. Hepatology 1998;27:1452-1453.
451. Kane KL, Folds JD: Infectious disease serology; in Leffell MS, Donnenberg AD, Rose NR, (eds): Handbook of Human Immunology, Boca Raton, FL, CRC, 1997, pp 142-148.
452. Kain SR, Mai K, Sinai P: Human multiple tissue Western blots: a new immunological tool for the analysis of tissue-specific protein expression. BioTechniques 1994; 17:982-987.
453. Teuber SS, Yoshida SH, Gershwin ME: Immunopathologic effects of silicone breast implants. West J Med 1995;162:418-425.
454. Andersen LG, Talal N: The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 1971; 9:199-221.
455. Duvic M, Moore D, Menter A, Vanderheld EC: Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol 1995;32:939-942.
456. Sendagorta E, Ledo A: Sézary syndrome in association with silicone breast implant. J Am Acad Dermatol 1995;33:1060-1061.
457. Benjamin E, Ahmed A, Eashid ATMF, Wright DH: Silicone lymphadenopathy: a report of two cases, one with concomitant malignant lymphoma. Diagn Histopath 1982;5:133-141.
458. Digby JM, Wells AL: Malignant lymphoma with intranodal refractile particles after insertion of silicone prostheses. Lancet 1981; 2:580.
459. Cook PD, Osborne BM, Connor RE, Strauss JF: Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol 1995; 19:712-717.
460. Sever CE, Leith CP, Appenzeller J, Foucar K: Kikucki's histiocytic necrotizing lymphadenitis associated with ruptured silicone breast implants. Arch Pathol Lab Med 1996;120:380-385.
461. Wagner MMF, Wagner JC: Lymphomas in the Wistar rat after intrapleural inoculation of silica. J Natl Cancer Inst 1972;49:81-91.
462. Wagner MM, Wagner JC: Production of lymphomata following intrapleural inoculation of silica. J Clin Pathol 1972;25:556.
463. Tricot GJK, Naucke S, Vaught L, Vesole D, Jagannath LS, Barloige B: Is the risk of multiple myeloma increased in patients with silicone implants?; in Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer-Verlag, 1996, pp 357-359.
464. Garland LL, Ballester OF, Vasey FB, Benson K, Moscinski LC, Farmelo MJ, Rodriguez MJ, Rapaport DP: Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk; in Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer-Verlag, 1996, pp 361-366.
465. Silverman S, Vescio R, Silver D, Renner S, Weiner S, Bereson J: Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance; in Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer- Verlag, 1996, pp 367-374.
466. Kyle K: Monoclonal gammopathy of undetermined significance; in Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer- Verlag, 1996, pp 375-383.
467. Rabkin CS, Silverman S, Tricot G, Garland LL, Ballester O, Potter M: The National Cancer Institute Silicone Implant/Multiple Myeloma Registry; in, Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer-Verlag, 1996, pp 385-387.
468. Herrinton LJ: The epidemiology of monoclonal gammopathy of unknown significance; in Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer- Verlag, 1996, pp 389-395.
469. Potter M, Morrison S: Plasmacytoma development in mice injected with silicone gels; in Potter M, Rose NR, (eds): Immunology of Silicones. Berlin, Springer- Verlag, 1996, pp 397-407.
470. Carter D: Interpretation of Breast Biopsies, 3rd ed. Philadelphia, Lippincott-Raven, 1996, pp 241- 242,325.
471. Toikkanen S.: Primary squamous cell carcinoma of the breast. Cancer 1981;48:1629-1632.
472. Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast: IV. Squamous cell carcinoma of ductal origin. Cancer 1990;65:272-276.
473. Kitchen SB, Paletta CE, Shehadi SI, Bauer WC: Epithelialization of the lining of a breast implant capsule: possible origin of squamous cell carcinoma associated with a breast implant capsule. Cancer 1994;73:1449-1452.
474. Talmor M, Rothaus KO, Shannahan E, Cortese AF, Hoffman LA: Squamous cell carcinoma of the breast after augmentation with liquid silicone injection. Ann Plast Surg 1995;34:619-623.
475. Moertel CG: The gallbladder; in Holland IF, Frei E, (eds): Cancer Medicine, 2nd ed. Philadelphia, Lea & Febiger, 1982. pp 1782-1785.
476. Kumagai Y, Abe C, Shiokawa Y: Scleroderma after cosmetic surgery: four cases of human adjuvant disease. Arthritis Rheumat 1979;22: 532-537.
477. Sahn EE, Garen PD, Silver RM, Maize JC: Scleroderma following augmentation mammoplasty: report of a case and review of the litera-ture. Arch Dermatol 1990;126:1198-1202.
478. Spiera H: Scleroderma after silicone augmentation mammoplasty. J Am Med Assoc 1988;260:236-238.
479. Spiera H, Kerr LD: Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 1993;20:958-961.
480. Appleton BE, Lee P: The development of systemic sclerosis (scleroderma) following augmentation mammoplasty. J Rheumatol 1993; 20:1052-1054.
481. Englert HJ, Howe, GB, Penny, R, Brooks P: Scleroderma and silicone breast implants. Br J Rheumatol 1994;33:397-399.
482. 482 Morse JH, Fotino M, Zhang Y, Plaster ER, Peebles CL, Spiera H: Position 26 of the first domain of the HLA-DQB1 allele in postsilicone implant scleroderma. J Rheumatol 1995;22:1872-1875.
483. Di Lorenzo G, Mansueto P, Melluso M, Sangiorgi GB, Cigna D, Candore G, Caruso C: Morphea after silicone gel breast implantation for cosmetic reasons in an HLA,DR3-positive woman. Int Arch Allergy Immunol 1997;112: 93-95.
484. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheumat 1980:23:581-590.
485. Peterson LS, Nelson AM, Su WPD: Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-1076.
486. Fox RI, Kang H-I: Genetic and environmental factors in systemic sclerosis. Curr Opin Rheumatol 1992;4:857-861.
487. Needleman BW: Immunologic aspects of scleroderma. Curr Opin Rheumatol 1992;4:862-868.
488. Smith EA: Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1992;4:869-877.
489. Bottomley WW, Sheehan-Dare RA, Hughes P, Cunliffe, WJ: A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol 1993:128:203-206.
490. Hennekens CH, Lee I-M, Cook NR, Hebert PR, Karlson EW, LaMotte F, Manson JE, Buring JE: Self-reported breast implants and connective-tissue diseases in female health professionals. J Am Med Assoc 1996;275:616-621.
491. Spiera RF, Gibofsky A, Spiera H: Scleroderma in women with silicone breast implants: comment on the article by Sanchez-Guerrero et al. Arthritis Rheumat 1995; 38:719-726.
492. Kumagai Y, Abe C, Hirano T, Fukuda Y, Shiokawa Y: Mixed connective tissue disease after breast augmentation which terminated in scleroderma kidney: an autopsy case report of human adjuvant disease. The Ryumachi 1981; 21(Supp.):171-176.
493. Okano Y, Nishikai M, Sato A: Scleroderma, primary biliary cirrhosis, and Sjîgren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheumat Dis 1984;43:520-522.
494. Sergott TJ, Limoli JP, Baldwin CM, Laub DR: Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 1985;78: 104-114.
495. Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH: Silicone breast implants and the risk of connectivetissue diseases and symptoms. N Engl J Med 1995;332: 1666-1670.
496. Nyrén O, Yin L, Josefsson S, McLaughlin JK, Blot WJ, Engqvist M, Hakelius L, Boice JD, Adami H-O: Risk of connective tissue disease and related disorders among women with breast implants: a nationwide retrospective cohort study in Sweden. BMJ 1998;316:1-6.
497. Shanklin DR, Smalley DL: Study adds nothing to knowledge of processes of tissue injury induced by silicone. BMJ 1998;317:470 (Letter).
498. Atherton JC: Authors should have made better use of matched control group. BMJ 1998;317:470 (Letter).
499. Brinton LA, Toniolo P, Pasternack BS: Epidemiological follow-up studies of breast augmentation patients. J Clin Epidemiol 1995: 48:557-563.
500. Pisetsky DS: Anti-DNA antibodies in systemic lupus erythematosus: a case of mistaken identity? J Rheumatol 1998;25:195-197.
501. Achauer BM: A serious complication following medical-grade silicone injection of the face. Plast Reconstr Surg 1983;71:251-254.
502. Rae V, Pardo RJ, Blackwelder PL, Falanga V: Leg ulcers following subcutaneous injection of a liquid silicone preparation. Arch Dermatol 1989;125:670-673.
503. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
504. Kosuda LL, Bigazzi PE: Chemical-induced autoimmunity; in Smialowicz RJ, Holsapple MP, (eds): Experimental Immunotoxicology, Boca Raton, FL, CRC, 1996, pp 419-465.
505. Kimber I: Chemical-induced hypersensitivity; in Smialowicz RJ, Holsapple MP, (eds): Experimental Immunotoxicology, Boca Raton, FL, CRC, 1996, pp 391-417.
506. Pettersson I, Hinterberger M: The structure of mammalian small nuclear ribonucleoproteins. J Biol Chem 1984;259:5907-5914.
507. Craft J, Fatenejad S: Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheumat 1997;40:1374-1382.
508. Hardin JA: The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheumat 1986;29:457-460.
509. Enterline PE: Pitfalls in epidemiological research. J Occup Med 1976;18:150-156.
510. Sherman JD: Cause-and-effect decisions based upon scientific opinion; in Chemical Exposure and Disease; Diagnostic and Investigative Techniques, Chapter 11. Princeton, NJ, Princeton Scientific, 1994, pp 197-219.
511. 511 Ruttenberg R, Bingham EA: A comprehensive occupational carcinogen policy as framework for regulatory activity. Ann NY Acad Sci 1981;363:13-20.
512. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Heavy LA, Kaplan SR, Kiang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumat 1988;31:315-324.
513. LeRoy EC, Maricq HR, Kahaleh MB: Undifferentiated connective tissue syndromes. Arthritis Rheumat 1980;23:341-343.
514. Swan SH: Epidemiology of silicone-related disease. Sem Arthritis Rheumat 1994;24(Suppl 1):38-43.
515. van Nunen SA, Gateby PA, Basten A: Post-mammoplasty connective tissue disease. Arthritis Rheumat 1982;25:694-697.
516. Love LA, Weiner SR, Vasey FB, Crofford LJ, Oddis CV, Starr MR, Bridges AJ, Targoff IN, Gurley RC, Miller FW: Clinical and immunogenetic features of women who developed myositis after silicone implants. Arthritis Rheumal 1992; 35:S46.
517. Blackburn WD, Grotting J, Everson MP: Lack of findings of systemic rheumatic disorders in "symptomatic" women with silicone breast implants. Arthritis Rheumat 1992;35:S212.
518. De Cholnoky T: Augmentation mammoplasty; a survey of complications in 10, 941 patients by 265 surgeons. Plast Reconstr Surg 1970;45:573-577.
519. Koeger AC, Wrona N, Sitbon E, Nicoletis C: Maladies autoimmunes associees aux protheses mammaires. Chirurgie 1993-94;119:618-625.
520. Miyoshi K, Miyaoka T, Kobayashi Y, Itakura T, Nishijo K, Higashibara M, Shiragami H, Ohno F: Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo 1964;2122:9-14.
521. Abe C: Human adjuvant disease, J Keio Med Soc 1972;49:177- 183.
522. Shiokawa Y, Nishino N, Shimada N, Warabi H, Okada T: Cases of the so-called adjuvant disease due to mammoplasty. Rinsho Meneki (Tokyo) 1972;4:389-396.
523. Miyoshi K, Shiragami H, Yoshida K: Adjuvant disease of man. Clin Immunol 1973;5:785-794.
524. Yoshida K: Post-mammoplasty disorder as an adjuvant disease of man. Shikoku Acta Med 1973;29:318-332.
525. Baldwin CM, Kaplan EN: Silicone-induced human adjuvant disease? Ann Plast Surg 1983; 10: 270-273.
526. Brozena SJ, Fenske NA, Cruse CW, Espinoza CG, Vasey FB, Germain FB, Espinoza LR: Human adjuvant disease following augmentation mammoplasty. Arch Dermatol 1988;124:1383-1386.
527. Patten BH, Shoaib BO: Disquisition on human adjuvant disease. Perspect Biol Med 1995;38: 274-290.
528. Shoaib BO, Patten BM: Human adjuvant disease: presentation as a multiple sclerosis-like syndrome. South Med J 1996;89:179-188.
529. Kumagai Y, Shiokawa Y, Medsger TA, Rodnan GP: Clinical spectrum of connective tissue disease after cosmetic surgery. Arthritis Rheumat 1984;27:1-12.
530. Boo-Chai K: The complications of augmentation mammaplasty by silicone injection. Br J Plast Surg 1969;22:281-285.
531. Rees TD, Ballantyne DL, Seidman I: Eyelid deformities caused by the injection of silicone fluid. Br J Plast Surg 1971;24:125-128.
532. Meyer DR, Bui HX, Carlson JA, Ratliff CD, Guevarra MC, Del- Rosario AD, Ross JS, Mihm M: Silicon granulomas and dermatomyositis-like changes associated with chronic eyelid edema after silicone breast implant. Ophthal Plast Reconstr Surg 1998;14:182-188.
533. Wilkie TF: Late development of granuloma after liquid silicone injection. Plast Reconstr Surg 1977; 60:179-188.
534. Pearl RM, Laub DR, Kaplan, EN: Complications following silicone injections for augmentation of the contours of the face. Plast Reconstr Surg 1978;61:888-891.
535. Chen Y-M, Chong-Chen L, Perng R-P: Silicone fluid-induced pulmonary embolism. Am Rev Respir Dis 1993;147:1299-1302.
536. Bergman RB, van der Ende AE: Exudation of silicone through the envelope of gel-filled breast prostheses: an in vitro study. Br J Plast Surg 1979:32:31-34.
537. Rubin LR: The deflating saline implant: facing up to complications. Plast Reconstr Surg 1980; 65:665 (Editorial).
538. Little G, Baker JL: Results of closed compression capsulotomy for treatment of contracted breast implant capsules. Plast Reconstr Surg 1980;65:30-33.
539. Mowry RG, Sams WM, Caulfield JB: Cutaneous silica granuloma. Arch Dermatol 1991; 127:692-694.
540. Gye WE, Purdy WJ: The poisonous properties of colloidal silica. I. The effects of the parenteral administration of large doses. Br J Exp Pathol 1922:3:75-94.
541. Gye WE, Purdy WJ: The poisonous properties of colloidal silica. III. Br J Exp Pathol 1922;5: 238-250.
542. 542 Wilflingseder P, Hoikes G, Mikuz G: Tissue reactions from silicone implant in augmentation mammaplasties. Minerva Chir 1983;38: 877-880.
543. Netscher DT, Walker LE, Weizer G, Thornby J, Wigoda P, Bowen D: A review of 198 patients (389 implants) who had breast implants removed. J Long-Term Effects Med Implants 1995;5:11-18.
544. Goldwyn RM: Breast reconstruction after mastectomy. N Engl J Med 1987;317:1711-1714.
545. Versaci AD: Reconstruction of a pendulous breast utilizing a tissue expander. Clin Plast Surg 1987; 14:499-508.
546. Melmed EP: A review of explantation in 240 symptomatic women: a description of explantation and capsulectomy with reconstruction using a periareolar technique. Plast Reconstr Surg 1998;101:1364-1373.
547. Kirwan L: Two cases of apparent silicone allergy. Plast Reconstr Surg 1995;96:236-237.
548. Atabey A, Barutçu A: Skin test for silicone implants. Plast Reconstr Surg 1996;98:1316-1317.
549. Boackle RJ, Draughn RA, Vesely J: Disruption of complement-mediated reactions by insoluble dentrifrice ingredients. J Periodontol 1981;52:621-625.
550. Brawer AE: Silicon and matrix macromolecules: new research opportunities for old diseases from analysis of potential mechanisms of breast implant toxicity. Med Hypotheses 1998;51:27-35.
551. Friedman RJ: Silicone breast prostheses implantation and explantation. Sem Arthritis Rheumal 1994; 24:8-10.
552. Vasey FB: Clinical experience with systemic illness in women with silicone breast implants: comment on the editorial by Rose. Arthritis Rheumat 1997;40:1545 (Letter).